Advertisement
Screener

Neuronetics, Inc. (STIM) Material Contracts

Neuronetics, Inc. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-08-11: Form 10-Q; Exhibit 10.9; Description Neuronetics, Inc. 2026 Equity Incentive Plan.
  • 2026-07-20: Form 8-K; Exhibit 10.2; Description Separation Agreement dated July 17, 2026 by and between the Company and W. Andrew Macan..
  • 2026-07-20: Form 8-K; Exhibit 10.1; Description Offer Letter, effective as of July 10, 2026, by and between the Company and Nir Naor..
  • 2026-05-22: Form 8-K; Exhibit 10.1; Description Amended and Restated Consulting Agreement by and between the Company and Francis X. Brown III dated May 18, 2026.
FiledFormExhibitDescription
2026-08-1110-Q10.9Neuronetics, Inc. 2026 Equity Incentive Plan
2026-07-208-K10.2Separation Agreement dated July 17, 2026 by and between the Company and W. Andrew Macan.
2026-07-208-K10.1Offer Letter, effective as of July 10, 2026, by and between the Company and Nir Naor.
2026-05-228-K10.1Amended and Restated Consulting Agreement by and between the Company and Francis X. Brown III dated May 18, 2026
2026-05-0510-Q10.10Amended and Restated Consulting Agreement, dated April 22, 2026, by and between the Company and Francis X. Brown III.
2026-04-068-K10.1Executive Consulting and Release Agreement by and between the Company and Keith J. Sullivan dated April 1, 2026
2026-03-1710-K10.54Third Amendment to Research Collaboration Agreement dated December 10, 2025 by and between by and between Compass Pathfinder Limited and TMS Neurohealth Centers, Inc.
2026-03-1710-K10.48Severance Agreement effective as of March 23, 2026 (anticipated) by and between the Company and Daniel L. Reuvers
2026-03-1710-K10.47Employment Agreement effective as of March 23, 2026 (anticipated) by and between the Company and Daniel L. Reuvers.
2026-03-1710-K10.25Employment Agreement, dated July 14, 2020, by and between the Registrant and Keith J. Sullivan, dated July 14, 2020, (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on July 17, 2020)
2026-03-1710-K10.7Amendment No. 5 and Waiver to Credit Agreement and Guaranty, dated March 12, 2026
2026-03-028-K10.1Amendment No. 2 to the Registration Rights Agreement by and between Neuronetics and Investor dated March 2, 2026
2026-01-228-K10.1Amendment No. 4 to Credit Agreement and Guaranty, dated January 15, 2026
2025-08-058-K10.1Amendment No. 3 to Credit Agreement and Guaranty, dated August 1, 2025
2025-07-158-K10.1Offer Letter, effective as of July 15, 2025, by and between the Company and Steven Pfanstiel.
2025-03-2710-K10.52Amendment No. 2 to Credit Agreement and Guaranty by and between the Company, as the borrower, and Perceptive, in its capacities as administrative agent for the lenders and the majority lender dated March 26, 2025
2025-03-2710-K10.49Second Amendment to Research Collaboration Agreement dated February 14, 2025 by and between Compass Pathfinder Limited and TMS Neurohealth Centers, Inc.
2025-03-2710-K10.48Amendment to Research Collaboration Agreement dated August 8, 2024 by and between Compass Pathfinder Limited and TMS Neurohealth Centers, Inc.
2025-03-2710-K10.33Form of Neuronetics, Inc. Restricted Stock Unit Grant Notice and Award Agreement under 2020 Inducement Incentive Plan
2025-03-2710-K10.32Form of Neuronetics, Inc. Performance Restricted Stock Unit Grant Notice and Award Agreement under the 2018 Equity Incentive Plan
2025-03-2710-K10.31Form of Neuronetics, Inc. Performance Restricted Stock Unit Grant Notice and Award Agreement under 2020 Inducement Incentive Plan
2025-03-2710-K10.25Non-Employee Director Compensation Policy
2025-03-2710-K10.24Form of Restrictive Covenant and Severance Agreement
2025-03-2710-K10.23Form of Restrictive Covenant and Invention Assignment Agreement
2025-03-2710-K10.22Form of Separation Agreement
2025-03-2710-K10.21Forms of Restricted Stock Unit Grant Notice and Award Agreement under the 2018 Equity Incentive Plan
2025-03-2710-K10.17First Amendment dated March 22, 2019 to Lease Agreement by and between Phoenixville Pike Owner LLC, and the Registrant
2024-12-108-K10.2Consent and Amendment No. 1 to Credit Agreement and Guaranty and Warrant Certificate dated December 9, 2024
2024-11-018-K10.1Amendment to the Registration Rights Agreement by and between Neuronetics and Investor dated November 1, 2024
2024-08-138-K10.4Form of Registration Rights Agreement by and between Neuronetics and Investor dated August 11, 2024
2024-08-138-K10.3Form of Voting and Support Agreement by and between Neuronetics and certain Greenbrook Locked-Up Shareholders dated August 11, 2024
2024-08-138-K10.2Form of Voting and Support Agreement by and between Neuronetics and certain Greenbrook Locked-Up Shareholders dated August 11, 2024
2024-08-138-K10.1Form of Voting and Support Agreement by and between Neuronetics and certain Greenbrook Locked-Up Shareholders dated August 11, 2024
2024-07-308-K10.1Credit Agreement and Guaranty, dated July 25, 2024, by and among Neuronetics, Inc., as the borrower, certain Subsidiaries of Neuronetics, Inc. from time to time party thereto, as guarantors, the lenders from time to time party thereto, and PERCEPTIVE CREDIT HOLDINGS IV, LP, in its capacity as the administrative agent for the lenders
2024-03-0810-K10.28Employment Offer Letter Agreement dated November 25, 2019 by and between the Registrant and Andrew Macan
2024-03-0810-K10.27Amended and Restated Restrictive Covenant and Severance Agreement dated November 2, 2023 by and between the Registrant and Keith J. Sullivan
2024-03-0810-K10.26Amended and Restated Employment Agreement, dated November 2, 2023 by and between the Registrant and Keith J. Sullivan
2024-03-0810-K10.22Form of Restrictive Covenant and Severance Agreement
2024-03-0810-K10.9Sixth Amendment to Loan and Security Agreement, dated March 7, 2024, by and among SLR Investment Corp. (formerly known as Solar Capital Ltd.), as collateral agent, the lenders listed on the signature pages thereto, and Neuronetics, Inc.
2023-10-038-K10.1Fifth Amendment to Loan and Security Agreement, dated September 29, 2023, by and among SLR Investment Corp. (formerly known as Solar Capital Ltd.), as collateral agent, the lenders listed on the signature pages thereto, and Neuronetics, Inc.
2023-04-048-K10.2Secured Promissory Note and Guaranty Agreement, dated March 31, 2023, by and among Neuronetics, Inc., TMS Neurohealth Centers Inc. and Greenbrook TMS Inc. and its subsidiaries listed on the signature pages thereto, as guarantors.
2023-04-048-K10.1Fourth Amendment to Loan and Security Agreement, dated March 29, 2023, by and among SLR Investment Corp. (formerly known as Solar Capital Ltd.), as collateral agent, the lenders listed on the signature pages thereto, and Neuronetics, Inc.
2022-05-058-K10.1Subordination Agreement, dated April 29, 2022
2022-02-228-K10.1Third Amendment to Loan and Security Agreement, dated February 15, 2022, by and among SLR Investment Corp. (formerly known as Solar Capital Ltd.), as collateral agent, the lenders listed on the signature pages thereto, and Neuronetics, Inc.
2021-10-058-K10.1Secured Promissory Note dated September 29, 2021
2021-08-0310-Q10.3Third Amended and Restated Bylaws of the Registrant
2021-08-0310-Q10.2Form of Restrictive Covenant and Severance Agreement
2021-05-0410-Q10.1Consulting Agreement, dated April 1, 2021 by and between Neuronetics, Inc. and Gregory Harper.
2020-12-088-K10.1Second Amendment to Loan and Security Agreement, dated December 2, 2020, by and among Solar Capital Ltd., as collateral agent, the lenders listed on the signature pages thereto, and Neuronetics, Inc.
2020-08-0410-Q10.8Stock Option Grant Notice and Agreement (Nonstatutory Stock Option), dated July 14, 2020, by and between Neuronetics, Inc. and Keith J. Sullivan.
2020-08-0410-Q10.7Restricted Stock Unit Grant Notice and Award Agreement, dated July 14, 2020, by and between Neuronetics, Inc. and Keith J. Sullivan.
2020-08-0410-Q10.6Performance Restricted Stock Unit Grant Notice and Award Agreement, dated July 14, 2020, by and between Neuronetics, Inc. and Keith J. Sullivan.
2020-08-0410-Q10.5Form of Neuronetics, Inc. Stock Option Grant Notice and Agreement (Nonstatutory Stock Option) under Nasdaq Listing Rule 5635(c)(4).
2020-08-0410-Q10.4Form of Neuronetics, Inc. Restricted Stock Unit Grant Notice and Award Agreement under Nasdaq Listing Rule 5635(c)(4).
2020-08-0410-Q10.3Form of Neuronetics, Inc. Performance Restricted Stock Unit Grant Notice and Award Agreement under the 2018 Equity Incentive Plan.
2020-08-0410-Q10.2Form of Neuronetics, Inc. Performance Restricted Stock Unit Grant Notice and Award Agreement under Nasdaq Listing Rule 5635(c)(4).
2020-07-178-K10.1Employment Agreement, dated July 14, 2020, by and between Neuronetics, Inc. and Keith J. Sullivan
2020-04-278-K10.1Paycheck Protection Program Note, dated as of April 21, 2020, by and between Neuronetics, Inc. and Silicon Valley Bank.
2020-04-138-K10.1Transition Services Agreement, dated as of April 8, 2020, by and between Neuronetics, Inc. and Christopher Thatcher
2020-03-038-K10.1Loan and Security Agreement, dated March 2, 2020, by and among Solar Capital Ltd., as collateral agent, the lenders listed on Schedule 1.1 thereto, and Neuronetics, Inc.
2019-08-0610-Q10.2First amendment to the distribution agreement, by and between the Registrant and Teijin Pharma Limited, dated May 31, 2019.
2019-07-028-K10.1Employment Offer Letter Agreement between Neuronetics, Inc. and Stephen Furlong dated July 1, 2019.
2018-11-0610-Q10.112018 Employee Stock Purchase Plan
2018-11-0610-Q10.102018 Equity Incentive Plan

Similar stocks

Stock NameCountryMarket CapPE Ratio
Profound Medical Corp. (PROF)$0.206B-7.37
PRO DEX INC (PDEX)United States$0.234B13.64
UTAH MEDICAL PRODUCTS INC (UTMD)United States$0.238B20.93
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52
Lucid Diagnostics Inc. (LUCD)United States$0.170B
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Cytosorbents Corp (CTSO)United States$0.274B-1.29
KORU Medical Systems, Inc. (KRMD)United States$0.151B-106.78
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92